Infection Control Market Size(US$)

CAGR 2026-2032
3.7%
Market Size,2032
USD 24,820
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Infection Control market was valued at US$ 19310 million in 2025 and is anticipated to reach US$ 24820 million by 2032, at a CAGR of 3.7% from 2026 to 2032.
The North American market for Infection Control is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Infection Control is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Infection Control in Hospitals & Clinics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Infection Control include STERIS, Getinge, Ecolab, 3M, Advanced Sterilization Products, Cantel Medical, Sotera Health, MMM Group, Matachana, Belimed AG, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Infection Control market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infection Control. The Infection Control market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Infection Control market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Infection Control manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Infection Control companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infection Control Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Disinfection Products
1.2.3 Sterilization Products and Services
1.3 Market by Application
1.3.1 Global Infection Control Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals & Clinics
1.3.3 Life Sciences Industry
1.3.4 Medical Device Companies
1.3.5 Pharmaceutical Companies
1.3.6 Food Industry
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infection Control Market Perspective (2021–2032)
2.2 Global Infection Control Growth Trends by Region
2.2.1 Global Infection Control Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Infection Control Historic Market Size by Region (2021–2026)
2.2.3 Infection Control Forecasted Market Size by Region (2027–2032)
2.3 Infection Control Market Dynamics
2.3.1 Infection Control Industry Trends
2.3.2 Infection Control Market Drivers
2.3.3 Infection Control Market Challenges
2.3.4 Infection Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infection Control Players by Revenue
3.1.1 Global Top Infection Control Players by Revenue (2021–2026)
3.1.2 Global Infection Control Revenue Market Share by Players (2021–2026)
3.2 Global Top Infection Control Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Infection Control Revenue
3.4 Global Infection Control Market Concentration Ratio
3.4.1 Global Infection Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infection Control Revenue in 2025
3.5 Global Key Players of Infection Control Head Offices and Areas Served
3.6 Global Key Players of Infection Control, Products and Applications
3.7 Global Key Players of Infection Control, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Infection Control Breakdown Data by Type
4.1 Global Infection Control Historic Market Size by Type (2021–2026)
4.2 Global Infection Control Forecasted Market Size by Type (2027–2032)
5 Infection Control Breakdown Data by Application
5.1 Global Infection Control Historic Market Size by Application (2021–2026)
5.2 Global Infection Control Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Infection Control Market Size (2021–2032)
6.2 North America Infection Control Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Infection Control Market Size by Country (2021–2026)
6.4 North America Infection Control Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infection Control Market Size (2021–2032)
7.2 Europe Infection Control Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Infection Control Market Size by Country (2021–2026)
7.4 Europe Infection Control Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Infection Control Market Size (2021–2032)
8.2 Asia-Pacific Infection Control Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Infection Control Market Size by Region (2021–2026)
8.4 Asia-Pacific Infection Control Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Infection Control Market Size (2021–2032)
9.2 Latin America Infection Control Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Infection Control Market Size by Country (2021–2026)
9.4 Latin America Infection Control Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infection Control Market Size (2021–2032)
10.2 Middle East & Africa Infection Control Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Infection Control Market Size by Country (2021–2026)
10.4 Middle East & Africa Infection Control Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 STERIS
11.1.1 STERIS Company Details
11.1.2 STERIS Business Overview
11.1.3 STERIS Infection Control Introduction
11.1.4 STERIS Revenue in Infection Control Business (2021–2026)
11.1.5 STERIS Recent Development
11.2 Getinge
11.2.1 Getinge Company Details
11.2.2 Getinge Business Overview
11.2.3 Getinge Infection Control Introduction
11.2.4 Getinge Revenue in Infection Control Business (2021–2026)
11.2.5 Getinge Recent Development
11.3 Ecolab
11.3.1 Ecolab Company Details
11.3.2 Ecolab Business Overview
11.3.3 Ecolab Infection Control Introduction
11.3.4 Ecolab Revenue in Infection Control Business (2021–2026)
11.3.5 Ecolab Recent Development
11.4 3M
11.4.1 3M Company Details
11.4.2 3M Business Overview
11.4.3 3M Infection Control Introduction
11.4.4 3M Revenue in Infection Control Business (2021–2026)
11.4.5 3M Recent Development
11.5 Advanced Sterilization Products
11.5.1 Advanced Sterilization Products Company Details
11.5.2 Advanced Sterilization Products Business Overview
11.5.3 Advanced Sterilization Products Infection Control Introduction
11.5.4 Advanced Sterilization Products Revenue in Infection Control Business (2021–2026)
11.5.5 Advanced Sterilization Products Recent Development
11.6 Cantel Medical
11.6.1 Cantel Medical Company Details
11.6.2 Cantel Medical Business Overview
11.6.3 Cantel Medical Infection Control Introduction
11.6.4 Cantel Medical Revenue in Infection Control Business (2021–2026)
11.6.5 Cantel Medical Recent Development
11.7 Sotera Health
11.7.1 Sotera Health Company Details
11.7.2 Sotera Health Business Overview
11.7.3 Sotera Health Infection Control Introduction
11.7.4 Sotera Health Revenue in Infection Control Business (2021–2026)
11.7.5 Sotera Health Recent Development
11.8 MMM Group
11.8.1 MMM Group Company Details
11.8.2 MMM Group Business Overview
11.8.3 MMM Group Infection Control Introduction
11.8.4 MMM Group Revenue in Infection Control Business (2021–2026)
11.8.5 MMM Group Recent Development
11.9 Matachana
11.9.1 Matachana Company Details
11.9.2 Matachana Business Overview
11.9.3 Matachana Infection Control Introduction
11.9.4 Matachana Revenue in Infection Control Business (2021–2026)
11.9.5 Matachana Recent Development
11.10 Belimed AG
11.10.1 Belimed AG Company Details
11.10.2 Belimed AG Business Overview
11.10.3 Belimed AG Infection Control Introduction
11.10.4 Belimed AG Revenue in Infection Control Business (2021–2026)
11.10.5 Belimed AG Recent Development
11.11 Halyard Health
11.11.1 Halyard Health Company Details
11.11.2 Halyard Health Business Overview
11.11.3 Halyard Health Infection Control Introduction
11.11.4 Halyard Health Revenue in Infection Control Business (2021–2026)
11.11.5 Halyard Health Recent Development
11.12 Metrex Research
11.12.1 Metrex Research Company Details
11.12.2 Metrex Research Business Overview
11.12.3 Metrex Research Infection Control Introduction
11.12.4 Metrex Research Revenue in Infection Control Business (2021–2026)
11.12.5 Metrex Research Recent Development
11.13 Reckitt Benckiser
11.13.1 Reckitt Benckiser Company Details
11.13.2 Reckitt Benckiser Business Overview
11.13.3 Reckitt Benckiser Infection Control Introduction
11.13.4 Reckitt Benckiser Revenue in Infection Control Business (2021–2026)
11.13.5 Reckitt Benckiser Recent Development
11.14 Pal International
11.14.1 Pal International Company Details
11.14.2 Pal International Business Overview
11.14.3 Pal International Infection Control Introduction
11.14.4 Pal International Revenue in Infection Control Business (2021–2026)
11.14.5 Pal International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
The global Infection Control market was valued at US$ 16880 million in 2023 and is anticipated to reach US$ 22490 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 89
USD 2900.00
(Single User License)
The global market for Infection Control was estimated to be worth US$ 16880 million in 2023 and is forecast to a readjusted size of US$ 22490 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030
Published Date: 2024-01-24
Pages: 108
USD 3950.00
(Single User License)
Market Analysis and Insights: Global Infection Control Market
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
The global market for Infection Control was valued at US$ 18690 million in the year 2024 and is projected to reach a revised size of US$ 24020 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published Date: 2025-02-27
Pages: 84
USD 2900.00
(Single User License)
The global market for Infection Control was estimated to be worth US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 117
USD 3950.00
(Single User License)
The global Infection Control market size was US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 96
USD 4250.00
(Single User License)
The global market for Infection Control was estimated to be worth US$ 19310 million in 2025 and is projected to reach US$ 24820 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 119
USD 3950.00
(Single User License)
The global Infection Control market was valued at US$ 16880 million in 2023 and is anticipated to reach US$ 22490 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 89
The global market for Infection Control was estimated to be worth US$ 16880 million in 2023 and is forecast to a readjusted size of US$ 22490 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030
Published: 2024-01-24
Pages: 108
Market Analysis and Insights: Global Infection Control Market
Published: 2024-04-12
Pages: 107
The global market for Infection Control was valued at US$ 18690 million in the year 2024 and is projected to reach a revised size of US$ 24020 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published: 2025-02-27
Pages: 84
The global market for Infection Control was estimated to be worth US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 117
The global Infection Control market size was US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 96
The global market for Infection Control was estimated to be worth US$ 19310 million in 2025 and is projected to reach US$ 24820 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published: 2026-07-15
Pages: 119
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research